Obesity - The Global Race for Treatments. Brain Waves: The field of neurotechnology, the focus of this blog, encompasses advances in brain science (neurons), information technology (bits) and bioengineering (genes). Up for discussion and analysis: the political, economic, ethical, and social forces that will shape the future of what will be one of the most important and fascinating stories of the coming decades.

About this author

Zack Lynch is author of The Neuro Revolution: How Brain Science Is Changing Our World (St. Martin's Press, July 2009).
He is the founder and executive director of the Neurotechnology Industry Organization (NIO) and co-founder of NeuroInsights. He serves on the advisory boards of the McGovern Institute for Brain Research at MIT, the Center for Neuroeconomic Studies, Science Progress, and SocialText, a social software company. Please send newsworthy items or feedback - to Zack Lynch.
Follow me on Twitter at @neurorev

Receive by email

GUEST AUTHOR ARCHIVES

In the Pipeline: Don't miss Derek Lowe's excellent commentary on drug discovery and the pharma industry in general at In the Pipeline

« DVD of Theoretical Neuroscience Meeting | Main | October Neurotech Public Market Summary »

October 31, 2005

Obesity - The Global Race for Treatments

Posted by Zack Lynch

As children munch away on candy corns, baby ruths and the wide assortment of candy they collected last night, some of them are becoming part of the growing "globesity" (global obesity) epidemic.

Over one billion people worldwide and approximately 130 million Americans are overweight or obese, according to a July 2005 report published by the World Health Organization. If current trends continue, that number will increase to 1.5 billion by 2015. Joining the many neuropharmaceutical companies developing new therapeutics to treat the escalating global epidemic of overweight and obesity – “globesity” – are a small cadre of neurodevice companies offering novel solutions.

cover%20neurotech%20insights%20obesity.jpg The potential of neurostimulation devices to treat a variety of diseases, such as epilepsy and chronic pain, is becoming widely appreciated. The neurostimulation market generated revenues of over $1 billion in 2004 with 20% growth, making it the fastest growing areas of medical devices. In most applications the technical principle is the same: a pacemaker-type device known as an Implantable Pulse Generator (IPG), delivers a precise pattern of stimulation via the appropriate nerve pathway to achieve the desired effect...

Obesity is very serious and growing (no pun intended), health problem which is why we have chosen to focus on the obesity market in this month's Neurotech Insights. To order the complete report please visit, www.neurotechinsights.com. Also included in this issue:

INSIDE THIS ISSUE: OCTOBER 31, 2005 - Obesity

Markets and Industry Players
Included: Pharmaceutical and Device Clinical Trials
Article: The Search for A Skinny Pill
Top News Alerts: People, Product Updates & Acquisitions
Featured Company: Arena Pharmaceuticals (ARNA)

Neurotech Insights is now available in Japanese too.

Comments (0) + TrackBacks (0) | Category: Neurotech Industry

POST A COMMENT

Thanks for signing in, . Now you can comment. (sign out)

(If you haven't left a comment here before, you may need to be approved by the site owner before your comment will appear. Until then, it won't appear on the entry. Thanks for waiting.)